Chemotherapy effectiveness and initiation time after lung cancer surgery

January 5, 2017

A new study suggests patients who recover slowly from non-small-cell lung cancer (NSCLC) surgery may still benefit from delayed chemotherapy started up to four months after surgery, according to a new study published online by JAMA Oncology.

Adjuvant after initial cancer surgery has become a standard recommendation for with NSCLC with , tumors that are four centimeters or larger or extensive local invasion of the cancer. While there is consensus regarding indications for chemotherapy after the initial cancer treatment, the optimal timing following surgical resection is poorly defined. Many clinicians support starting chemotherapy within six weeks after surgery. But factors such as postoperative complications may affect a patient's ability to tolerate chemotherapy.

Daniel J. Boffa, M.D., of the Yale School of Medicine, New Haven, Conn., and coauthors used data from patients in the National Cancer Database to examine the relationship between the timing of postoperative chemotherapy and five-year mortality.

The study of 12,473 patients with stage I, II or III disease who received multi-agent chemotherapy suggests that later chemotherapy (57 to 127 postoperatively) was not associated with increased risk of death and later chemotherapy also was associated with a lower risk of death compared with those patients treated only with surgery, according to the results.

Limitations of the study include that it cannot establish causality.

"Patients with completely resected NSCLC in the NCDB [National Cancer Database] continue to benefit from when given outside the traditional postoperative window. Clinicians should still consider chemotherapy in appropriately selected patients that are healthy enough to tolerate it, up to four months after NSCLC resection. Further study is warranted to confirm these findings," the article concludes.

Explore further: Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer

More information: JAMA Oncol. Published online January 5, 2017. DOI: 10.1001/jamaoncol.2016.5829

Related Stories

Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer

June 13, 2016
The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 - 7 cm.

Medulloblastoma patients should receive both chemotherapy and radiation post-surgery

September 26, 2016
In a recent study, a Yale Cancer Center team revealed that the addition of chemotherapy to postoperative treatment for adults with medulloblastoma improves survival. The benefit of chemotherapy, in addition to craniospinal ...

Some breast cancer patients on neoadjuvant chemo may avoid axillary lymph node dissection

December 7, 2016
A sentinel lymph node biopsy (SLNB) during surgery that showed no signs of cancer was associated with a low risk for breast cancer recurrence in the axillary (armpit) lymph nodes for patients with large, operable breast tumors ...

Multimodality treatment for metastatic lung cancer with surgery may improve survival rates

June 10, 2015
Patients diagnosed with an advanced form of metastatic non-small cell lung cancer (NSCLC) may benefit from surgical resection (removal of all or part of the lung) in combination with chemotherapy and radiation therapy, according ...

Ceritinib provides longer PFS than chemo in phIII trial of ALK rearranged lung cancer

October 9, 2016
Ceritinib provides longer progression-free survival than chemotherapy in crizotinib-pre-treated patients with non-small-cell lung cancer harbouring an ALK rearrangement, according to results of the phase III ASCEND-5 study ...

Adjuvant chemotherapy in early-stage colon cancer may improve survival

July 15, 2016
Researchers and physicians have grappled with the role of "adjuvant," or post-surgery, chemotherapy for patients with early-stage colon cancer, even for cancers considered high risk. Now researchers from the University of ...

Recommended for you

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

October 12, 2017
High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.